Pentixapharm Holding AG (PTP) | WebDisclosure

Basculer en Français

8295	Companies
114846	Keywords
55288	Articles
62438	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 11/21/2024 at 11:05, 34 minutes ago

Pentixapharm fait progresser les essais cliniques pour le traitement de la leucémie

Essai Clinique Produits Radiopharmaceutiques Pentixapharm Lu-177 Traitement De La Leucémie
BRIEF

published on 11/21/2024 at 11:05, 34 minutes ago

Pentixapharm Advancing Clinical Trials for Leukemia Treatment

Clinical Trial Radiopharmaceuticals Pentixapharm Lu-177 Leukemia Treatment
PRESS RELEASE

published on 11/21/2024 at 11:00, 39 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Pentixapharm starts Phase I/II trial treating leukemia with Lu177-PentixaTher, a targeted radiotherapy. Study aims to expand treatment options for hematologic malignancies

Phase I/II Trial Leukemia Pentixapharm Radiotherapy Lu177-PentixaTher
BRIEF

published on 11/12/2024 at 17:50, 8 days 17 hours ago

Pentixapharm Reports Third Quarter 2024 Interim Results

Interim Report Spin-off Financial Loss Third Quarter Pentixapharm
BRIEF

published on 11/12/2024 at 17:50, 8 days 17 hours ago

Pentixapharm publie ses résultats intermédiaires du troisième trimestre 2024

Perte Financière Spin Off Rapport Intérimaire Pentixapharm Troisième Trimestre
PRESS RELEASE

published on 11/12/2024 at 17:45, 8 days 17 hours ago

Pentixapharm Releases Interim Report for the Third Quarter of 2024
Pentixapharm Holding AG releases interim report for third quarter of 2024, reporting a loss of €49k with no revenue. Anticipates significant increase in losses for 2024 consolidated annual financial statements

Financial Statements Revenue Interim Report Loss Pentixapharm
BRIEF

published on 11/04/2024 at 17:31, 16 days 18 hours ago

Pentixapharm Applauds CMS Reimbursement Enhancement for Radiopharmaceuticals

Radiopharmaceuticals Pentixapharm CMS Decision Reimbursement Policy Diagnostic Innovation
BRIEF

published on 11/04/2024 at 17:31, 16 days 18 hours ago

Pentixapharm salue l'amélioration du remboursement des produits radiopharmaceutiques par le CMS

Produits Radiopharmaceutiques Pentixapharm Décision Du CMS Politique De Remboursement Innovation Diagnostique
PRESS RELEASE

published on 11/04/2024 at 17:26, 16 days 18 hours ago

Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals
Pentixapharm welcomes CMS decision to enhance reimbursement for diagnostic radiopharmaceuticals, which could impact future streams for Ga68-PentixaFor and have broader market implications

Radiopharmaceuticals Reimbursement Pentixapharm Ga68-PentixaFor CMS Decision
BRIEF

published on 10/29/2024 at 11:51, 22 days 23 hours ago

PentixaFor de Pentixapharm entre dans la phase d'essais cliniques avancés aux États-Unis

Essai Clinique Pentixapharm PentixaPour Tumeurs Surrénales Les Examens PET

1 2 ... 4

Accesswire

Published on 11/21/2024 at 10:03, 1 hour 36 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 39 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 39 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 4 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 11 hours 14 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:01, 38 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 39 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 42 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 9 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 1 hour 34 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 41 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 31 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 19 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE